Health Catalyst (HCAT) Competitors $1.29 0.00 (0.00%) Closing price 05/21/2026 04:00 PM EasternExtended Trading$1.30 +0.00 (+0.39%) As of 05/21/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCAT vs. RPD, BLZE, PERI, SWMR, and XPERShould you buy Health Catalyst stock or one of its competitors? MarketBeat compares Health Catalyst with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health Catalyst include Rapid7 (RPD), Backblaze (BLZE), Perion Network (PERI), Swarmer (SWMR), and Xperi (XPER). These companies are all part of the "computer software" industry. HCAT vs. RPDHCAT vs. BLZEHCAT vs. PERIHCAT vs. SWMRHCAT vs. XPERHow does Health Catalyst compare to Rapid7?Health Catalyst (NASDAQ:HCAT) and Rapid7 (NASDAQ:RPD) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Do analysts prefer HCAT or RPD? Health Catalyst presently has a consensus target price of $2.77, indicating a potential upside of 114.94%. Rapid7 has a consensus target price of $8.71, indicating a potential upside of 23.03%. Given Health Catalyst's stronger consensus rating and higher probable upside, equities analysts clearly believe Health Catalyst is more favorable than Rapid7.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Catalyst 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.23Rapid7 3 Sell rating(s) 17 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.95 Which has better valuation & earnings, HCAT or RPD? Rapid7 has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Rapid7, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Catalyst$311.14M0.31-$177.97M-$3.72N/ARapid7$859.79M0.55$23.38M$0.3520.23 Which has more volatility and risk, HCAT or RPD? Health Catalyst has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Rapid7 has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Does the media prefer HCAT or RPD? In the previous week, Health Catalyst and Health Catalyst both had 5 articles in the media. Rapid7's average media sentiment score of 0.00 beat Health Catalyst's score of -0.19 indicating that Rapid7 is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Rapid7 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals have more ownership in HCAT or RPD? 85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 95.7% of Rapid7 shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by company insiders. Comparatively, 2.4% of Rapid7 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is HCAT or RPD more profitable? Rapid7 has a net margin of 2.61% compared to Health Catalyst's net margin of -87.69%. Rapid7's return on equity of 34.35% beat Health Catalyst's return on equity.Company Net Margins Return on Equity Return on Assets Health Catalyst-87.69% -3.52% -1.77% Rapid7 2.61%34.35%2.78% SummaryRapid7 beats Health Catalyst on 10 of the 15 factors compared between the two stocks.How does Health Catalyst compare to Backblaze?Health Catalyst (NASDAQ:HCAT) and Backblaze (NASDAQ:BLZE) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Which has more volatility and risk, HCAT or BLZE? Health Catalyst has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market. Comparatively, Backblaze has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Does the media prefer HCAT or BLZE? In the previous week, Health Catalyst had 4 more articles in the media than Backblaze. MarketBeat recorded 5 mentions for Health Catalyst and 1 mentions for Backblaze. Backblaze's average media sentiment score of 0.27 beat Health Catalyst's score of -0.19 indicating that Backblaze is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Backblaze 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, HCAT or BLZE? Backblaze has lower revenue, but higher earnings than Health Catalyst. Backblaze is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Catalyst$311.14M0.31-$177.97M-$3.72N/ABackblaze$149.89M2.96-$25.61M-$0.39N/A Do analysts recommend HCAT or BLZE? Health Catalyst presently has a consensus price target of $2.77, indicating a potential upside of 114.94%. Backblaze has a consensus price target of $8.00, indicating a potential upside of 8.55%. Given Health Catalyst's higher probable upside, equities analysts clearly believe Health Catalyst is more favorable than Backblaze.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Catalyst 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.23Backblaze 2 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.60 Is HCAT or BLZE more profitable? Backblaze has a net margin of -14.97% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat Backblaze's return on equity.Company Net Margins Return on Equity Return on Assets Health Catalyst-87.69% -3.52% -1.77% Backblaze -14.97%-20.54%-8.90% Do insiders & institutionals believe in HCAT or BLZE? 85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 54.0% of Backblaze shares are held by institutional investors. 2.6% of Health Catalyst shares are held by company insiders. Comparatively, 4.2% of Backblaze shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryBackblaze beats Health Catalyst on 9 of the 17 factors compared between the two stocks.How does Health Catalyst compare to Perion Network?Perion Network (NASDAQ:PERI) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership. Does the media refer more to PERI or HCAT? In the previous week, Perion Network had 5 more articles in the media than Health Catalyst. MarketBeat recorded 10 mentions for Perion Network and 5 mentions for Health Catalyst. Perion Network's average media sentiment score of 0.68 beat Health Catalyst's score of -0.19 indicating that Perion Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Perion Network 2 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, PERI or HCAT? Perion Network has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market. Do insiders and institutionals have more ownership in PERI or HCAT? 68.1% of Perion Network shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 2.8% of Perion Network shares are held by company insiders. Comparatively, 2.6% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts rate PERI or HCAT? Perion Network presently has a consensus price target of $13.88, suggesting a potential upside of 56.96%. Health Catalyst has a consensus price target of $2.77, suggesting a potential upside of 114.94%. Given Health Catalyst's higher probable upside, analysts clearly believe Health Catalyst is more favorable than Perion Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perion Network 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60Health Catalyst 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.23 Which has higher earnings and valuation, PERI or HCAT? Perion Network has higher revenue and earnings than Health Catalyst. Perion Network is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerion Network$439.93M0.78-$7.93M-$0.18N/AHealth Catalyst$311.14M0.31-$177.97M-$3.72N/A Is PERI or HCAT more profitable? Perion Network has a net margin of -2.17% compared to Health Catalyst's net margin of -87.69%. Perion Network's return on equity of 3.29% beat Health Catalyst's return on equity.Company Net Margins Return on Equity Return on Assets Perion Network-2.17% 3.29% 2.47% Health Catalyst -87.69%-3.52%-1.77% SummaryPerion Network beats Health Catalyst on 11 of the 15 factors compared between the two stocks.How does Health Catalyst compare to Swarmer?Swarmer (NASDAQ:SWMR) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations. Is SWMR or HCAT more profitable? Swarmer has a net margin of 0.00% compared to Health Catalyst's net margin of -87.69%. Swarmer's return on equity of 0.00% beat Health Catalyst's return on equity.Company Net Margins Return on Equity Return on Assets SwarmerN/A N/A N/A Health Catalyst -87.69%-3.52%-1.77% Which has higher earnings and valuation, SWMR or HCAT? Swarmer has higher earnings, but lower revenue than Health Catalyst. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSwarmer$219.54K1,781.05N/AN/AN/AHealth Catalyst$311.14M0.31-$177.97M-$3.72N/A Do insiders & institutionals have more ownership in SWMR or HCAT? 85.0% of Health Catalyst shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate SWMR or HCAT? Health Catalyst has a consensus target price of $2.77, indicating a potential upside of 114.94%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst is more favorable than Swarmer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Swarmer 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Health Catalyst 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.23 Does the media prefer SWMR or HCAT? In the previous week, Health Catalyst had 2 more articles in the media than Swarmer. MarketBeat recorded 5 mentions for Health Catalyst and 3 mentions for Swarmer. Swarmer's average media sentiment score of 0.25 beat Health Catalyst's score of -0.19 indicating that Swarmer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Swarmer 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryHealth Catalyst beats Swarmer on 7 of the 12 factors compared between the two stocks.How does Health Catalyst compare to Xperi?Health Catalyst (NASDAQ:HCAT) and Xperi (NYSE:XPER) are both small-cap computer software companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Does the media prefer HCAT or XPER? In the previous week, Health Catalyst had 5 more articles in the media than Xperi. MarketBeat recorded 5 mentions for Health Catalyst and 0 mentions for Xperi. Xperi's average media sentiment score of 1.00 beat Health Catalyst's score of -0.19 indicating that Xperi is being referred to more favorably in the news media. Company Overall Sentiment Health Catalyst Neutral Xperi Positive Which has more risk & volatility, HCAT or XPER? Health Catalyst has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market. Comparatively, Xperi has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Is HCAT or XPER more profitable? Xperi has a net margin of -10.22% compared to Health Catalyst's net margin of -87.69%. Xperi's return on equity of 1.09% beat Health Catalyst's return on equity.Company Net Margins Return on Equity Return on Assets Health Catalyst-87.69% -3.52% -1.77% Xperi -10.22%1.09%0.73% Do analysts prefer HCAT or XPER? Health Catalyst currently has a consensus price target of $2.77, indicating a potential upside of 114.94%. Xperi has a consensus price target of $11.00, indicating a potential upside of 46.18%. Given Health Catalyst's higher possible upside, analysts plainly believe Health Catalyst is more favorable than Xperi.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Catalyst 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.23Xperi 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Do insiders and institutionals believe in HCAT or XPER? 85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 94.3% of Xperi shares are held by institutional investors. 2.6% of Health Catalyst shares are held by insiders. Comparatively, 3.2% of Xperi shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation & earnings, HCAT or XPER? Xperi has higher revenue and earnings than Health Catalyst. Xperi is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Catalyst$311.14M0.31-$177.97M-$3.72N/AXperi$448.11M0.81-$56.34M-$0.99N/A SummaryXperi beats Health Catalyst on 11 of the 16 factors compared between the two stocks. Get Health Catalyst News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAT vs. The Competition ExportMetricHealth CatalystMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$95.32M$1.46B$6.34B$12.29BDividend YieldN/AN/A2.79%5.33%P/E Ratio-0.3564.0621.0825.34Price / Sales0.316.27530.5585.48Price / Cash0.6122.7744.1356.16Price / Book0.696.3610.027.01Net Income-$177.97M-$54.76M$3.55B$335.27M7 Day Performance8.40%5.64%2.52%1.28%1 Month Performance-1.53%10.59%-0.47%0.16%1 Year Performance-64.66%1.41%36.43%34.54% Health Catalyst Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCATHealth Catalyst2.2418 of 5 stars$1.29flat$2.77+114.9%-65.5%$95.32M$311.14MN/A1,200RPDRapid72.1566 of 5 stars$6.40+0.4%$8.71+36.2%-69.1%$426.58M$859.79M18.242,613BLZEBackblaze2.4347 of 5 stars$6.84-4.4%$8.00+17.0%+32.6%$412.05M$145.84MN/A270PERIPerion Network4.8865 of 5 stars$10.45-2.8%$14.13+35.2%-16.7%$408.25M$439.93MN/A420Trending NewsEarnings ReportAnalyst ForecastSWMRSwarmerN/A$35.87+7.9%N/AN/A$391.14M$309.92KN/A62Gap Up Related Companies and Tools Related Companies RPD Alternatives BLZE Alternatives PERI Alternatives SWMR Alternatives XPER Alternatives TBRG Alternatives ECX Alternatives SPT Alternatives XNET Alternatives ISSC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCAT) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredI had never heard of this 1888 accountAn investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...The Oxford Club | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredHow to Profit from Elon’s AI lab before it goes publicElon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...InvestorPlace | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
